Several studies reported that reactive oxygen species (ROS) participate in the activation of NF-κB, a key player in tumorigenesis, and that excess ROS produced by cancer cells trigger tumor invasion and angiogenesis via NF-κB-mediated MMP-9 activation [10], [11]. This evidence concerns the gene MMP9 and cancer.